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REGULASI PENGAKTIFAN DAN KEFUNGSIAN SEL T SECARA 
NEGATIF OLEH PROTEIN PENYESUAI CIN85  
 
 
ABSTRAK 
 
Pengenalpastian antigen oleh reseptor sel T (TCR) mendorong jalur isyarat 
intraselular yang menyebabkan pengaktifan sel T, seterusnya mendorong 
percambahan sel dan pelbagai fungsi efektor. Protein penyesuai memainkan peranan 
dalam sel T dengan mewujudkan nod untuk merekrut protein isyarat dan membentuk 
isyarat kompleks yang mengawal selia arah isyarat sel. Casitas B-lineage Lymphoma 
(Cbl)-protein interaksi 85 kDa (CIN85) ialah protein penyesuai, asalnya dikenali 
sebagai protein mengikat Cbl dan dicadangkan terlibat dalam internalisasi dan 
degradasi reseptor dan kinase. Walau bagaimanapun, fungsi fisiologi CIN85 dalam 
sel T tidak diketahui. Untuk memahami peranan CIN85 dalam fungsi sel T, mencit 
yang dihapuskan gen cin85 (khususnya dalam sel T sahaja) (CIN85-KO) telah dijana 
dan diguna sebagai model untuk analisis dalam kajian ini. Sel T naïf CIN85-KO 
menunjukkan reaksi hyper terhadap stimulasi TCR, iaitu penghasilan interleukin-2, 
percambahan sel T dan pengubahsuaian perbezaan kepada T helper jenis 1 fenotip 
menigkat dengan ketara. Hal ini mencadangkan CIN85 menunjukkan regulasi negatif 
dalam aktivasi sel T. Analisa molekul isyarat menunjukkan pemfosforilan tirosine 
pada molekul jaluran-TCR seperti rantai-zeta yang berkaitan protein kinase 70 kDa 
(Zap70), protein SH2 domain mengandungi leukosit protein 76 kDa (SLP-76), 
fosfolipase C-gamma (PLCγ), c-Jun-N-terminal kinase (JNK) dan isyarat 
dikawal-luar sel kinase (ERK), telah dipertingkatkan dengan ketara dalam sel T 
CIN85-KO. Data ini mengimplikasikan bahawa CIN85 terlibat dalam awal isyarat 
  xx 
kompleks TCR untuk mengawalkan selia negatif aktivasi sel T. Mencit CIN85-KO 
menunjukkan jumlah penduduk sel T efektor/memori CD44hi yang lebih tiggi dalam 
perifer. Hal ini membuktikan bahawa CIN85 memainkan peranan penting dalam 
pemeliharaan homeostasis sel T in vivo. Memandangkan internalisasi TCR yang 
didorong oleh rangsangan tidak berubah dalam sel T CIN85-KO berbanding dengan 
mencit ‘wild-type’. CIN85 tidak berperanan dalam proses endositosis reseptor, 
seperti yang dicadangkan dalam kajian dengan menggunakan jenis sel yang lain. 
Selepas aktivasi TCR, CIN85 didapati ‘co-localize’ bersama TCR mikrokluster 
(TCR-MCs). Kekurangan protein CIN85 dalam sel T tidak menjejaskan 
pembentukan TCR-MCs dan kluster-kluster SLP-76. Dalam pencarian molekul 
berikatan dengan CIN85, penindas isyarat-2 TCR (Sts-2) fosfatase telah ditunjukkan 
berinteraksi dengan CIN85 setelah rangsangan TCR, untuk aktiviti CIN85 dalam 
regulasi negatif terhadap aktivasi sel T. Kedua-dua domain Src homologi rantau 3 
(SH3) dan rantau proline kaya (PR) kepunyaan CIN85 adalah penting untuk interaksi 
CIN85 dengan Sts-2. Keseluruhannya, data-data dalam kajian ini menunjukkan 
CIN85 mengawal aktivasi dan pembentukkan sel T secara negatif, melalui 
keupayaannya merekrut Sts-2 kepada isyarat kompleks supaya ia menjalankan proses 
difosforilasi terhadap Zap70 yang telah diaktifkan. Ini adalah penting untuk 
mencegah reaksi berlebihan yang berkemungkinan membawa penyakit autoimun. 
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NEGATIVE REGULATION OF T CELL ACTIVATION AND FUNCTION 
BY CIN85 ADAPTOR PROTEIN 
 
ABSTRACT 
 
Antigen recognition by T cell receptor (TCR) induces intracellular signaling 
cascades leading to T cell activation, subsequently inducing cellular proliferation and 
various effector functions. Adaptor proteins play important roles in T cell signaling 
by creating nodes to recruit signaling proteins and form signal complexes to regulate 
the direction of signaling. Casitas B-lineage lymphoma (Cbl)-interacting protein of 
85 kDa (CIN85) is an adaptor protein, originally identified as a Cbl-binding protein, 
and was suggested to be involved in the internalization and degradation of receptors 
and kinases. Nevertheless, the physiological function of CIN85 in T cells is unknown. 
To understand the role of CIN85 in T cell function, T cell-specific CIN85-knockout 
(KO) mice were generated and analyzed in this study. CIN85-KO naïve T cells were 
found to exhibit hyper-responsiveness to TCR stimulation; i.e. significantly 
increased interleukin 2 (IL-2) production, cell proliferation and alteration of 
differentiation into T helper type 1 (Th1) phenotypes, suggesting that CIN85 exhibits 
negative regulation in T cell activation. Analysis of signaling molecules showed that 
tyrosine phosphorylation of TCR-downstream molecules, such as ζ-chain associated 
protein kinase of 70 kDa (Zap70), SH2 domain-containing leukocyte protein of 76 
kDa (SLP76), phospholipase C-gamma (PLCγ), c-Jun-N-terminal kinase (JNK) and 
extracellular-signal-regulated kinase (ERK), were significantly enhanced in 
CIN85-KO T cells. This implied that CIN85 was involved in the early TCR signaling 
complex to negatively regulate T cell activation. As for T cell development, 
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CIN85-KO mice were found to display higher population of CD44hi 
effector/memory-type T cells at the periphery, suggesting an important role of CIN85 
in maintaining the homeostasis of T cells in vivo. Since stimulation-induced TCR 
internalization was not altered in CIN85-KO T cells, CIN85 in T cells was unlikely 
to have played a role in the endocytosis as suggested in other cell types. Upon TCR 
stimulation, CIN85 was shown to co-localize with TCR microclusters (TCR-MCs); 
deficiency of CIN85 caused no impairment to TCR-MCs and SLP76-cluster 
formation. Suppressor of TCR signaling-2 (Sts-2) phosphatase was found to bind to 
CIN85 upon TCR stimulation, which is important for CIN85-mediated negative 
regulation of T cell activation. Both Src homology region 3 (SH3) domains and 
proline-rich (PR) region of CIN85 were found to be crucial for the CIN85-Sts-2 
interactions. Collectively, these data showed that CIN85 negatively regulates T cell 
activation and development, through its ability to recruit Sts-2 to the signaling 
complex for its dephosphorylation activity on activated Zap70. This is important to 
prevent overreaction that might lead to autoimmune disease. 
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1 CHAPTER ONE 
 INTRODUCTION 
 
1.1 Immune system 
Despite continuous exposure to pathogenic microorganisms, we rarely fall sick. How 
does the body defend itself? The immune system consists of a variety of effector 
cells and molecules to defend the body from environmental agents, such as infectious 
microorganisms and harmful substances or chemicals.  
 
Traditionally, immunity is classified into innate and adaptive immune systems with 
distinct properties and functions (Hoebe et al., 2004). This classification is essential 
for understanding and compartmentalization of the immune system; nevertheless, our 
immune system practically functions as a single unit rather than distinct entities 
(Murphy et al., 2008).  
 
Innate immunity is recognized to respond rapidly and vigorously to combat a wide 
range of pathogens, but also can cause damage to normal healthy tissues due to loss 
of specificity for antigenic discrimination and lack of memory for lasting immunity 
(Parkin & Cohen, 2001; Hansson et al., 2002). Innate immunity is also known as a 
phylogenetically ancient defense mechanism, which exploits a limited number of 
germline-encoded pattern-recognition receptors (PRRs). PRRs recognize the 
evolutionary conserved structures of pathogens, which are known as 
pathogen-associated molecular patterns (PAMPs) (Medzhitov & Janeway, 2000; 
Akira et al., 2006; Mogensen, 2009). PAMPs include lipopolysaccharides (LPS) (a 
major component of the outer membrane of Gram-negative bacteria), lipoteichoic 
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acids (LTA) (cell wall polymer of Gram-positive bacteria), peptidoglycans 
(component of a mesh-like layer at outer membrane of most bacteria), mannans and 
glucans (fungal cell wall components), and microbial nucleic acids (e.g. bacterial 
DNA and viral DNA/RNA) (Medzhitov & Janeway Jr, 1997; McCance & Huether, 
2010; Vincent, 2011). 
 
In contrast, adaptive immunity induces antigen-specific immune response, which is 
long lasting. It is developed through adaptation when encountering specific 
pathogens during the individual’s lifetime (Murphy et al., 2008; Rimer et al., 2014). 
Adaptive immunity is characterized as relatively delayed-response compared to 
innate immunity. It utilizes specific immune receptors and exhibits immunological 
memory that confers life-long protective immunity to reinfection with the same 
pathogen (Gowans & Uhr, 1966; Borghesi & Milcarek, 2007). Adaptive immunity is 
an immune mechanism that uniquely manifests itself in vertebrate animals (Rimer et 
al., 2014). 
 
Both innate and adaptive immune responses depend on the activity of leukocytes 
(white blood cells). Innate immunity includes neutrophils, monocytes and 
macrophages (phagocytosis), dendritic cells, basophils, mast cells and eosinophils 
(release inflammatory mediators), and natural killer cells (cytotoxic lymphocytes) 
(Shaykhiev & Bals, 2007; Murphy et al., 2008). Physical, chemical and 
microbiological barriers, and molecular components, such as complement, 
acute-phase proteins and some cytokines, are also encompassed in innate immunity 
(Medzhitov & Janeway, 2000; Basset et al., 2003). On the other hand, adaptive 
immunity utilizes B lymphocytes (B cells) and T lymphocytes (T cells) with highly 
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specialized surface receptors that recognize and respond to individual antigens 
(Hansson et al., 2002). 
 
All immune cells are derived from pluripotent hematopoietic stem cells (HSCs) that 
originate in the bone marrow (Domen et al., 2006). These stem cells give rise to both 
the common myeloid progenitor cells (basophils, neutrophils, eosinophils, 
erythrocytes, monocytes, macrophages and mast cells) and the common lymphoid 
progenitor cells (T cells, B cells and NK cells). Many of these precursor immune 
cells develop and mature in the bone marrow. For example, B cells undergo 
maturation within the bone marrow. However, T cells are the only hematopoietic 
cells that are generated in the thymus as the precursor cells migrate from the bone 
marrow into the thymus and develop as thymocytes (Schultz & Grieder, 1987; 
Germain, 2002; Park et al., 2010; Simeoni et al., 2008). Both the bone marrow and 
the thymus are referred to as the central or primary lymphoid organs, where the 
lymphocytes are generated (Murphy et al., 2008). 
 
The lymphocytes then migrate out of the primary lymphoid organs via the lymphatic 
and blood circulating system into the secondary or peripheral lymphoid organs, i.e. 
spleen, lymph nodes and mucosal associated lymphoid tissue (MALT) to defend the 
body (Ng & Chalasani, 2008). Adaptive immune responses are initiated at the 
peripheral lymphoid organs, in which lymphocytes recirculate until they encounter 
their specific foreign antigens. This recognition induces lymphocyte activation, 
proliferation and differentiation into effector cells that migrate to the site of infection 
and launch effector responses to combat the pathogen (Alberts et al., 2008).  
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The adaptive immune system comprised the humoral immune system and the cellular 
immune system, which are mediated by B cells and T cells, respectively. T and B 
cells use antigen-specific receptors expressed on their cell surfaces to drive targeted 
effector responses. Each lymphocyte bears unique variant of prototype 
antigen-specific receptors during its early stage of development (before exposure to 
antigen) (Chaplin, 2010). Random rearrangement and splicing of multiple DNA 
segments of genes that encode for the antigen-binding region of the receptor results 
in a huge repertoire of about 1011 possible TCR (Arstila et al., 1999) and over 1012 
antibody specificities (Alberts et al., 2008; Glanville et al., 2009) that enable 
adequate coverage of the wide variety of pathogens that an individual will probably 
encounter during a life time. TCR is further explained in Chapter 1.3.  
 
1.2 T cell immunity 
T cell-mediated immunity is also used as the terminology for cellular immunity that 
involves antigen-specific T lymphocytes, which mainly functions to eliminate 
bacterial, viral and parasitic infections as well as malignant cells (Broere et al., 2011). 
T cells mount effective immune response, basically in two stages (Figure 1.1). Firstly, 
presenting antigen via the major histocompatibility complex (MHC) molecule on 
antigen-presenting cells (APCs) or infected cells recognized and bound by 
antigen-specific TCR, and hereafter leading to T-cell priming, activation, 
proliferation and differentiation into functional forms (armed effector cells) that 
launch immune response, either directly by killing infected cells (cytolytic activity of 
CD8+ cytotoxic T cells) or indirectly by secreting various types of cytokines that 
orchestrate the responses of B cells to produce antibodies in the humoral immune 
response (T-cell dependent B cell response) (Delves & Roitt, 2000a; Alberts et al., 
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2008; van den Boorn, 2006). Integration of co-stimulatory signals with TCR 
signaling are required for optimal TCR activation, further details are explained in 
Chapter 1.4. Subsets of effector T cells and TCR composition are further explained 
in detail in the later part of Chapter 1.2 and Chapter 1.3, respectively. 
 
It is because B cells are unable to be activated by most antigens without “help” from 
helper T cells, therefore the activation of naïve T cells is indispensable in the initial 
stage of the adaptive immune response (Mak & Saunders, 2004). In addition to the 
role of T cell as an initiator of antigen-specific immunity, it also functions as an 
important regulator of the adaptive immune response. Hence, any aberrancy of T cell 
activation may lead to disease. 
 
 
Figure 1.1: The roles and functions of T and B lymphocytes in adaptive immunity 
(figure modified from Parkin & Cohen, 2001). 
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T cell-mediated immunity plays a central role in the adaptive immune response, 
including primary response by naïve T cells, effector functions by activated T cells 
and long-lasting memory response by antigen-specific memory T cells (Warrington 
et al., 2011). Distinct T cell populations are distinguished by surface molecules 
CD44 and CD62L; naïve T cells (CD44lo CD62Lhi), effector memory T cells (CD44hi 
CD62Llo) and central memory T cells (CD44hi CD62Lhi) (Swain et al., 1996; Sondel 
et al., 2003). Naive T cells are considered mature T cells that have successfully 
undergone central selection (positive and negative selections) in the thymus (Bosco 
et al., 2009). Thymic selection is further explained in Chapter 1.4. In contrast, 
memory T cells are T cells that are antigen-experienced with a specific set of TCR, 
which allows memory T cells to survive for years but allowing rapid immunological 
response when they are re-exposed to the same antigen subsequently 
(McHeyzer-Williams et al., 1996; Brenchley et al., 2002). 
 
The mature T cell population can be subdivided into several categories based on their 
lineage markers and functional activities. The most common groups are defined by 
two major surface co-receptors, CD4 and CD8 (Swain, 1983), which are expressed 
on T cell surface membrane and differ in their MHC restriction and function 
(Germain, 2002; Wang et al., 2009). Pathogen peptide (antigen) presentation by 
MHC molecules depend mainly on their origin, as typically MHC class I (MHC-I) 
and MHC class II (MHC-II) molecules display endogenously synthesized peptides 
and internalized exogenous antigens, respectively, on their cell membrane (Watts, 
1997; Blum et al., 2013; Mantegazza et al., 2013). CD8+ T cells are only able to 
recognize antigens that are associated with MHC-I molecules (Swain, 1981; Swain et 
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al., 1981; Norment et al., 1988) while CD4+ T cells are only able to recognize 
antigens that are displayed on MHC-II molecules (Doyle & Strominger, 1987). 
 
Upon antigen recognition, naïve T cells are activated and differentiate into several 
functional subsets of effector T (Teff) cells with specialized activities (Figure 1.2). 
Naïve CD8+ T cells differentiate into cytotoxic T lymphocytes (CTLs) that 
particularly function to recognize and kill infected cells and tumor cells. Conversely, 
CD4+ T cells have higher flexibility in terms of repertoire of effector activities. 
Naïve CD4+ T cells could differentiate into T helper (Th) cell subpopulations with a 
variety of effector functions (Anderson et al., 2014; Pen et al., 2014) and regulatory 
T (Treg) cells that have inhibitory function to limit the extent of immune activation 
(Sakaguchi, 2005). Th cell subsets are classified on the basis of their cytokine 
secretion profiles and play critical functions by coordinating the immunological 
activities (Luckheeram et al., 2012). 
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Figure 1.2: T cell fates in adaptive immunity 
 
Currently, the main functional Th cell subsets recognized are Th1, Th2, Th17 and T 
follicular helper (Tfh) cells (Mosmann & Coffman, 1989; Breitfeld et al., 2000; 
Akbar et al., 2007; Peck & Mellins, 2010; Crome et al., 2010). Functionally, effector 
Th cells are induced when naïve T cells are stimulated through TCR engagement by 
specific antigen under the guidance of developmental cues, such as cytokines 
produced by innate immune cells (Striz et al., 2014). Th cells exhibit important host 
defense functions. Nevertheless, dysregulated or uncontrolled Teff cell responses 
may cause immune pathogenesis. 
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As shown in Figure 1.3, Th1 cells that produce IL-2 and interferon-gamma (IFN-γ) 
elicit delayed-type hypersensitivity responses (pro-inflammatory cell-mediated 
immunity), activate macrophages (phagocyte-dependent inflammation), and enhance 
clearance of intracellular pathogens. These cells can also be linked to various chronic 
autoimmune diseases, if they are involved in aberrant recognition of self-antigens. 
Th2 cells produce IL-4, IL-5, IL-9 and IL-13. They are vital to control certain 
parasitic infections and critical in allergic responses (Arthur & Mason, 1986; 
Mosmann et al., 1986; Mosmann & Coffman, 1989; Abbas et al., 1996). Th17 cells 
are important in regulating tissue inflammatory reactions and autoimmune disease 
induction via production of IL-17 and IL-22 (Harrington et al., 2005; Park et al., 
2006). Tfh cells are localized in the follicles of secondary lymphoid organs, such as 
spleen, lymph nodes and the Peyer’s patches, and they play critical roles in helping B 
cells to differentiate into plasma cells through production of IL-21 for humoral 
immunity (King et al., 2008; Glatman Zaretsky et al., 2009). 
 
T cell stimulation not only induces proliferation, differentiation and effector T cell 
function for immune response activation, but also induces immune tolerance. There 
are several mechanisms that have been proposed to maintain immune tolerance by 
removing or neutralizing autoreactive T cells that have potential to recognize 
self-antigens as harmful substances. These immune tolerance mechanisms include 
immunosuppressive cytokine-producing Treg cells, T cell anergy (unresponsiveness), 
and activation-induced T cell apoptosis (cell death) (Van Parijs & Abbas, 1998; Xing 
& Hogquist, 2012) (Figure 1.2).  
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Figure 1.3: Cytokine profile and functions of CD4+ helper T cells 
 
Most of the T cells bearing TCR with specificity to thymic expressed self-antigens 
are deleted during development in the thymus (central tolerance), which is further 
discussed in Chapter 1.4. Although central tolerance is effective in eliminating 
autoreactive T cells, however not all self-antigens are expressed in the thymus. These 
extrathymic self-antigens include antigens that are only expressed at particular 
developmental stages, tissue-specific antigens that are exclusively expressed at the 
periphery, innocuous environmental peptides found in foods, and etc (Mondino et al., 
1996). Therefore, peripheral tolerance at the periphery is an important mechanism to 
tightly regulate against autoimmune disease.  
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1.3 T cell receptor (TCR) composition  
T cells recognize antigens via a cell surface antigen receptor, known as TCR. TCR is 
a membrane-anchored heterodimeric protein composed of TCRα and TCRβ 
polypeptide chains bearing highly variable antigen-binding regions. TCR only binds 
to a portion of an antigen (epitope) that is displayed or presented on the surface of 
host cell, but not to soluble antigens (Kam & Power, 2012; Campbell et al., 2015). 
TCR dimers can recognize and bind to specific antigenic peptides in combination 
with the MHC molecules (pMHC), but are unable to transduce signal into the cells 
(Bjorkman, 1997).  
 
TCRα/β heterodimer is associated with the CD3 complex, which is composed of 
three dimers; γε, δε and ζζ that are involved in TCR-dependent signal transduction 
(Figure 1.4) (Irving et al., 1993; Cantrell, 1996; Kirchgessner et al., 2001). All the 
CD3 chains contain a conserved sequence motif important for signaling termed 
immunoreceptor tyrosine-based activation motif (ITAM) (Reth, 1989; Underhill & 
Goodridge, 2007). ITAMs transmit antigen-recognition signals into the interior of the 
cell upon antigen binding through its phosphorylation. As shown in Figure 1.4, each 
CD3ε, δ and γ molecule has a single ITAM, while CD3ζ molecule has three copies of 
ITAMs. Hence each TCR-CD3 complex contains a total of ten ITAMs (Weiss & 
Littman, 1994; Love & Hayes, 2010). 
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Figure 1.4: Schematic diagram of the T cell receptor/CD3 (TCR-CD3) complex 
expressed on T cell membrane (Broere et al., 2011). 
 
1.4 T cell development 
T cell activation is tightly regulated to ensure triggering responses only occur to 
harmful foreign antigens but not to self-antigens. This objective is mainly achieved 
by thymic education (central tolerance), included positive and negative selection of 
thymocytes in the thymus (Berg et al., 2002). 
 
In thymic selection, CD4, CD8 and the TCR complex are important surface 
molecules to identify different thymocyte subsets (Erf et al., 1998; Bosselut, 2004). 
Following generation in the bone marrow, lymphoid progenitor cells migrate to the 
thymus through the bloodstream to undergo development into T cells. Through 
interaction with the thymic stromal cells, these lymphoid progenitor cells are 
Plasma membrane
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triggered to proliferate and commit to T cell lineage (thymocytes), and subjected to a 
series of selection processes in the thymus (Kruisbeek, 1999; Anderson et al., 2007). 
 
Progenitor T cells enter the thymus at cortico-medullary junction. Since these T cell 
progenitors in the initial immature stage lack expression of CD4 and CD8 molecules, 
as well as TCR on the cell surface, they are called double-negative (DN) thymocytes 
(Figure 1.5) (Koch & Radtke, 2011). DN thymocytes migrate to subcapsular region 
of the thymic cortex and undergo the process of TCR gene rearrangements 
(recombination of TCRβ, γ and δ genes followed by TCRα gene rearrangement) and 
eventually generate two T cell lineages of mature thymocytes: the majority of 
thymocytes with TCRαβ and the minority with TCRγδ (Raulet et al., 1991; Capone 
et al., 1998; Livák et al., 1999).  
 
Gene rearrangement of TCRβ-chain locus occurs in αβ committed DN cells, 
productive in-frame β chain is then paired with pre-TCRα (pTα) surrogate chain to 
form pre-TCR that enables it to be expressed on the cell surface (von Boehmer & 
Fehling, 1997). Pre-TCR-CD3 complex assembly leads to cell proliferation, arrest 
further β-chain locus gene arrangement (allelic exclusion) and expresses both CD4 
and CD8 on the surface of the same cell, generating double-positive (DP) 
thymocytes (Figure 1.5). This series of events induced by pre-TCR signal is 
collectively known as β-selection checkpoint (Groettrup & von Boehmer, 1993; 
Levelt et al., 1995). Later, DP cells stop proliferating and α-chain locus starts to 
rearrange in these small resting DP cells. Due to somatic recombination of TCR 
genes, up to millions of different clonotypic variants of distinct TCRαβ with random 
specificities can be synthesized. DP cells then lower the expression level of TCRαβ, 
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and CD3 complex associated with the TCR heterodimer. Eventually, these DP 
thymocytes are eligible for selection (van Oers et al., 1995; Schnell et al., 2006). 
 
 
Figure 1.5: T cell maturation and development in the thymus (Parkin & Cohen, 
2001). 
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Thymic selection is a critical event in T cell development, resulting in survival of 
self-restricted cells (positive selection) and death of self-reactive/autoreactive cells 
(negative selection) (Robey & Fowlkes, 1994; Jameson et al., 1995) (Figure 1.5). DP 
cells that can recognize self-MHC molecules on cortical thymic epithelial cells are 
positively selected. But those that bear ‘useless’ TCR that fails to recognize 
self-MHC molecules will undergo programmed cell death referred to as “death by 
neglect” because low avidity engagement between TCR and MHC molecule could 
not provide enough TCR signaling to sustain cell viability (Egerton et al., 1990; 
Anderson et al., 1996). This lineage fate is determined by the restriction specificity 
of TCR to MHC molecules, i.e. CD8 for MHC-I and CD4 for MHC-II molecules 
(Singer et al., 2008). Furthermore, DP cells are also undergoing negative selection in 
thymus to eliminate the potential threat of autoreactive cells to healthy host cells. 
Those cells that possess high avidity TCR binding towards self-peptide presented by 
MHC complex (self-pMHC) on thymic dendritic cells (DCs) and macrophages, are 
directed to cell death. Positively selected DP cells migrate from the cortex to the 
medulla after receiving cues for survival and ultimately differentiating into CD4+ or 
CD8+ single-positive (SP) thymocytes (Murphy et al., 2008; Xing & Hogquist, 2012). 
Mature SP cells are eventually exported to the periphery as mature naïve SP CD4+ or 
CD8+ T cells. 
 
During T cell development, thymocytes express distinctive cell surface proteins, 
which are useful markers that differentiate thymocytes at different stages of 
development. With particular combination of these surface markers, stages of 
differentiation and populations of T cells can be identified. There are several surface 
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markers that are commonly used for mouse thymocyte development studies, 
including CD24, CD69, CD5, and etc.  
 
CD69 and CD5 surface expression are commonly used as indicators of positive and 
negative selection for DP thymocytes. Thymocytes have 4 distinct stages of 
development and can be defined by the expression of CD3 and CD69 molecules. 
CD3lo CD69- cells represent DN cells and pre-selection DP thymocytes, CD3int 
CD69+ cells represent thymocytes that undergoing positive selection, CD3hi CD69+ 
cells represents post-positive-selected immature SP cells and CD3hi CD69- cells 
represents mature SP cells (Lesourne et al., 2009; Wang et al., 2012).  
 
CD5 has been shown to negatively regulate TCR signaling (Tarakhovsky et al., 
1995). In a study on CD5 deficient mice, the fate of DP thymocytes was shown to 
shift from weak positive selection towards higher efficiency of positive selection or 
weaker negative selection, or to shift from strong positive selection towards low 
efficiency of positive selection or stronger negative selection, depending on the 
specificity of TCR transgenic (Tg) mice used. It was suggested that CD5-mediated 
signal inhibition for thymic selection was strongly dependent on the avidity of the 
positive selecting TCR-MHC ligand interaction (Azzam et al., 2001). 
 
CD24, also known as heat-stable antigen (HSA), expression decreased as the cells 
undergo maturation in SP cells (Crispe & Bevan, 1987). CD24 is used as a 
maturation marker and its expression level can be used to divide SP cells into two 
populations; CD24hi and CD24lo SP cells as mature and immature cells, respectively.  
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In addition to this, the members of the Bcl-2 family, i.e. Bcl-2 and Bcl-xL were 
shown to have function as pro-survival factors of thymocytes and peripheral T cells. 
Bcl-2 was shown to confer survival advantage in DP cells by inhibiting negative 
selection (Williams et al., 1998; Siegel et al., 1992), whereas Bcl-xL was suggested 
to salvage and elevate maturation of CD8SP cells independent of selection 
background (Chao & Korsmeyer, 1997). 
 
At the peripheral lymphoid organs, naïve T cells circulate continuously until they 
encounter corresponding antigens presented by APCs, such as DCs and macrophages. 
Among APCs, DCs are the most efficient “professional” APCs due to their ability to 
provide co-stimulatory signals for full activation of T cells (Kooten & Banchereaut, 
1997). Optimal TCR activation requires both TCR-induced signals and 
co-stimulatory signals. TCR engaged without co-stimulatory signals is insufficient 
for full activation of T cells and leads T cells to anergic state that eventually results 
in T cells rendered non-responsive to subsequent antigen stimulation (Mueller et al., 
1989; Pentcheva-Hoang et al., 2009).  
 
Co-stimulatory molecules are important to enhance TCR signaling by producing 
antigen-independent signals (second signal) in addition to antigen-specific signal 
through TCR (first signal) for full T cell activation (Macián et al., 2004; Dustin, 
2005). The first signal is responsible for antigen-specific immune response, while 
second signal is implicated in T cell adhesion and/or TCR signal enhancement 
(Abraham et al., 1999). Requirement of co-stimulatory signals was proposed as a 
mechanism for maintaining peripheral T cell tolerance since co-stimulatory ligands 
are strictly provided by professional APCs (Chambers et al., 2001). 
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There are a number of surface co-stimulatory molecules that are important for T cell 
activation, including CD80/CD86 (B7-1/B7-2) and lymphocyte function-associated 
antigen-1 (LFA-1) that binds to co-receptors CD28 and intracellular adhesion 
molecule-1 (ICAM-1) of T cells, respectively (Figure 1.6) (June et al., 1990; Delves 
& Roitt, 2000b; Parkin & Cohen, 2001).  
 
 
Figure 1.6: Cell surface molecules involved in T cell activation (Parkin & Cohen, 
2001). 
 
In contrast, co-receptors such as cytotoxic T lymphocyte antigen 4 (CTLA-4) and 
programmed death-1 (PD-1) were found to transduce inhibitory signals that are 
implicated in negative regulation of T cell responses. Negative regulatory 
mechanisms not only function to terminate activation signals triggered by 
extracellular mediators, but also to set the signaling threshold for T cell activation. 
CTLA-4 binds to the same ligands CD80/CD86, as CD28. PD-1 has two ligands, 
which are PD-ligand 1 (PD-L1) and PD-ligand 2 (PD-L2). Co-inhibitory signals 
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(negative second signals) are feedback mechanisms triggered by T cell activation, 
which function to limit T cell responses, mediate peripheral tolerance and prevent 
autoimmunity (Chambers et al., 2001; Chen, 2004; Parry et al., 2005; Vigan et al., 
2012).  
 
1.5 T cell response 
T cells recognize antigen presented by APCs upon cell-cell contact. During contact, a 
specialized junction structure is generated at the interface between T cells and APCs, 
which is known as the immunological synapse (IS) (Dustin & Cooper, 2000; Kupfer 
& Kupfer, 2003; Huppa & Davis, 2003).  
 
IS is characterized by segregated molecular rearrangements resembling a bulls-eye 
(Figure 1.7); a central region containing TCR, called central supramolecular 
activation cluster (cSMAC), which is surrounded by a ring of LFA-1 as a peripheral 
SMAC (pSMAC) and the most external ring enriched of large ectodomain proteins 
including protein tyrosine phosphatases CD45, known as a distal SMAC (dSMAC) 
(Monks et al., 1998; Freiberg et al., 2002). 
 
As shown in Figure 1.7, the cSMAC structure (pink) contains the key molecules for 
T cell signaling, e.g. TCR-CD3 complex provides antigen-specific signals for T cell 
activation and the accessory molecules such as CD4 and CD28. Recently, cSMAC 
was suggested to be involved in signal termination through TCR internalization and 
degradation (Alarcón et al., 2011). pSMAC (green), on the other hand, consists 
mainly of cytoskeletal or adhesion molecules, such as integrin, LFA-1 which serves 
to support cell adhesion and also IS maintenance (Monks et al., 1998; Grakoui et al., 
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1999). dSMAC (grey) is an active membrane movement area involve in centripetal 
movement of TCR-MCs. TCR-MC is further discussed later. A number of studies 
suggested that dSMAC corresponds to lamellipodial actin structure and pSMAC 
corresponds to lamellar actin structure. Both pushing force (actin polymerization) in 
dSMAC and pulling force (actomyosin contraction) in pSMAC coordinate 
TCR-MCs movement across the IS to the cSMAC (Dustin, 2007; Krummel, 2007; 
Sims et al., 2007; Yi et al., 2012). 
 
 
Figure 1.7: Schematic diagram of the immunological synapse (IS) formation on the 
interface between a T cell and an antigen-presenting cell (APC) with enriched 
molecules found in each SMAC zone (figure modified from Huppa & Davis, 2003). 
 
It has been clarified that at early stages of contact, small clusters of TCR complexes 
accumulation termed “TCR microclusters” (TCR-MCs) are generated on the 
interface of T cells and APCs, which contain major upstream molecules of TCR 
signaling (Yokosuka et al., 2005; Varma et al., 2006). TCR-MCs are responsible to 
initiate and sustain signals for T cell activation through recruitment of kinases and 
adaptor proteins to form a ‘signalosome’ complex (Jordan et al., 2003; Yokosuka et 
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al., 2005; Saito & Yokosuka, 2006). TCR-MCs continuously generated at the 
periphery of the IS in an actin-dependent manner and later translocate to the central 
of IS to form the cSMAC (Figure 1.8) (Krummel et al., 2000; Varma et al., 2006; 
Campi et al., 2005). 
 
The IS functions not only to initiate/boost TCR signaling but also attenuate strong 
signals by TCR endocytosis and degradation (Lee et al., 2002; Lee et al., 2003). 
TCR signaling is sustained in TCR-MCs and then terminated at cSMAC, where 
TCRs are sorted for degradation (Figure 1.8) (Varma et al., 2006; Yokosuka et al., 
2008). T cell activation signals must be tightly regulated through multiple levels of 
positive and negative regulations, otherwise autoimmunity (excessive) or 
immunodeficiency (defective) might result, and TCR down-regulation is one of the 
principal mechanisms of negative regulation of T cell activation. 
 
In the homeostatic state, a part of the TCR-CD3 complexes on plasma membrane of 
T cells constitutively undergo internalization and recycling back to cell membrane 
(Krangel, 1987; Minami et al., 1987). Upon TCR ligation, the surface expression of 
TCR is rapidly reduced as the TCR-CD3 complexes are internalized/endocytosed 
and either rapidly recycles to the cell surface or targeted for degradation through 
lysosome compartments. TCR internalization was suggested to play a critical role in 
regulating T cell activation by attenuating TCR signaling upon stimulation (Valitutti 
et al., 1995; Valitutti et al., 1996; Valitutti et al., 1997). 
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Figure 1.8: Dynamic process of TCR microclusters (TCR-MCs) and supramolecular 
activation cluster (cSMAC) formation on planar bilayer system (slide modified from 
Saito & Yokosuka, 2006). 
 
1.6 TCR signaling cascades 
In T cells, all their functions, i.e. proliferation, cytokine production and effector T 
cell differentiation are controlled largely by TCR signaling (Sebzda et al., 1999; 
Singer & Koretzky, 2002). Engagement of TCR by the pMHC on the APCs initiates 
antigen-recognition signal, which is then translated into transmembrane signal and 
induces an array of intracellular signaling cascades through activation of kinases and 
tyrosine phosphorylation of many signaling molecules. These include the TCR/CD3 
complex and also proteins assembly to form the signaling complex containing 
adaptors and effector enzymes. These immediate events are referred to as proximal 
TCR signaling (Kane et al., 2000; Germain, 2001; Samelson, 2002; Jordan et al., 
2003). The intracellular signaling cascades ultimately determine the direction and 
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fate of the T cells, i.e. induction of specific functions, cytokine production, cell 
proliferation, transcription activation for cellular differentiation, effector functions, 
anergy or cell death, which are essential for the onset of a productive immune 
response (Unanue, 1984; Weiss et al., 1987; Crabtree, 1989).  
  
As shown in Figure 1.9, antigen recognition by TCR initially induces the 
phosphorylation of ITAMs within CD3 molecules, especially CD3ζ chains by 
lymphocyte-specific protein tyrosine kinase (Lck). Phosphorylated ITAMs provide 
docking sites for a spleen tyrosine kinase (Syk) family of kinases, Zap70 through its 
two tandem Src homology region 2 (SH2) domains and Zap70 is then 
phosphorylated by Lck (Chan et al., 1994; Hatada et al., 1995). Zap70 then acquires 
increased enzymatic activity to further activate several other downstream adaptor 
proteins, including two critical adaptor proteins, i.e. linker for activation of T cells 
(LAT) and SLP-76 (Chan et al., 1994).  
 
LAT is an integral membrane protein that localizes in the plasma membrane and it 
plays an important role to recruit numerous signaling molecules. Four key tyrosine 
residues within LAT are phosphorylated by Zap70 and resulted in recruitment of 
signaling molecules, including SLP76, PLCγ1, Vav 1 guanine nucleotide exchange 
factor (VAV1) and growth factor receptor-bound protein 2 (Grb2) to form a 
multiprotein complex, known as LAT signalosome (Zhang & Samelson, 2000). 
Activation of LAT and SLP76 then recruit additional signaling molecules, leading to 
the activation of downstream signaling pathways that branches into several distinct 
signal pathways (Figure 1.9) (Kane et al., 2000; Brownlie & Zamoyska, 2013). 
 
  24 
Activation of these signaling molecules then propagate the signals which branches to 
actin reorganization, calcium influx, the mitogen-activated protein kinase (MAPK) 
and the nuclear factor-κB (NF-κB) signaling pathways. All these effector cascades 
then lead to mobilization of transcription factors, which are critical for transcriptional 
activation of genes that play an essential role for cellular proliferation and 
differentiation. Besides, TCR signals also result in cytoskeletal reorganization and 
activation of integrins by inside-out signaling (Brownlie & Zamoyska, 2013). 
 
Figure 1.9: Overview of T cell receptor-dependent intracellular signaling cascades 
